Net profit of Concord Biotech declined 15.07% to Rs 64.48 crore in the quarter ended December 2025 as against Rs 75.92 crore during the previous quarter ended December 2024. Sales rose 13.74% to Rs 277.77 crore in the quarter ended December 2025 as against Rs 244.22 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 277.77 | 244.22 | 14 |
| OPM % | 35.38 | 40.11 | - |
| PBDT | 108.18 | 114.42 | -5 |
| PBT | 89.44 | 101.15 | -12 |
| NP | 64.48 | 75.92 | -15 |